Showing results (321-330 of 476) with videos related to

Sort By:
Pageof 48
Journal of the American College of Surgeons|August 1, 1997
The surgical risk of pancreas transplantation in the cyclosporine era: an overviewR W Gruessner, D E Sutherland, C Troppmann, et al.
The Journal of Clinical Investigation|October 1, 1984
Structural-functional relationships in diabetic nephropathyS M Mauer, M W Steffes, E N Ellis, et al.
The Journal of Experimental Medicine|March 1, 1973
The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritisS M Mauer, D E Sutherland, R J Howard, et al.
The Journal of Experimental Medicine|April 1, 1974
Renal transplantation in diabetes mellitus in ratsC S Lee, S M Mauer, D M Brown, et al.
American Journal of Surgery|November 1, 1987
Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprineT W Frick, D S Fryd, D E Sutherland, et al.
The New England Journal of Medicine|July 13, 1989
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetesR W Bilous, S M Mauer, D E Sutherland, et al.
Journal of Biomedical Materials Research|November 1, 1992
Toxic effect of ethylene-oxide-sterilized freeze-dried bone allograft on human gingival fibroblastsV L Kudryk, M J Scheidt, M J McQuade, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1986
Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipientsU J Hesse, D S Fryd, S N Chatterjee, et al.
Transplantation|August 5, 2000
Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantationR M Merion, M L Henry, J S Melzer, et al.
The Journal of Experimental Medicine|July 1, 1990
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allograftsD B Kaufman, J L Platt, F L Rabe, et al.
Pageof 48